What is Cera?
Founded in 2016 and headquartered in London, UK, Cera is a prominent provider of in-home health care services. The company's core mission is to enable patients to receive comprehensive care within the comfort and familiarity of their own homes, thereby improving quality of life and reducing the burden on traditional healthcare facilities. Cera leverages technology and a network of professional caregivers to deliver personalized and efficient healthcare solutions.
How much funding has Cera raised?
Cera has raised a total of $327M across 2 funding rounds:
Series A
$7M
Other Financing Round
$320M
Series A (2020): $7M with participation from JJDC , Inc., Atlantic Labs, and Asabys Partners Company
Other Financing Round (2022): $320M led by Schroders Capital, KairosHQ, and Jane Street Capital
Key Investors in Cera
Schroders Capital
Schroders Capital is an investment firm that likely focuses on providing significant capital for established companies or specific strategic initiatives, given the scale of this funding round.
KairosHQ
KairosHQ is an investor participating in this significant funding round, contributing to Cera's strategic growth objectives.
Jane Street Capital
Jane Street Capital is a quantitative trading firm that also engages in strategic investments, likely backing Cera's innovative approach to healthcare delivery.
What's next for Cera?
The recent major strategic investment signals a new phase of expansion for Cera. This capital infusion is expected to fuel further development of its service infrastructure, enhance its technological capabilities, and potentially broaden its geographical footprint. The company's focus on the growing demand for home-based care positions it for continued scaling and innovation within the health tech industry. Future strategic partnerships and further funding rounds may be anticipated as Cera solidifies its market leadership.
See full Cera company page
